Urinary NT-proBNP, NGAL, and H-FABP may predict hemodynamic relevance of patent ductus arteriosus in very low birth weight infants

Neonatology

Volumn 101, Issue 4, 2012, Pages 260-266

  Tosse, Veronika ^a   Pillekamp, Frank ^a   Verde, Pablo ^a   Hadzik, Berit ^a   Sabir, Hemmen ^a   Mayatepek, Ertan ^a   Hoehn, Thomas ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

H FABP; NGAL; NT proBNP; Patent ductus arteriosus; Preterm infant

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; FATTY ACID BINDING PROTEIN; HEART FATTY ACID BINDING PROTEIN; IBUPROFEN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODYNAMICS; HUMAN; INFANT; MALE; NEWBORN; NON INVASIVE MEASUREMENT; PATENT DUCTUS ARTERIOSUS; PEDIATRIC CARDIOLOGY; PREMATURITY; PRIORITY JOURNAL; PROTEIN URINE LEVEL; TREATMENT PLANNING; VERY LOW BIRTH WEIGHT;

ACUTE-PHASE PROTEINS; BIRTH WEIGHT; CASE-CONTROL STUDIES; DUCTUS ARTERIOSUS, PATENT; FATTY ACID-BINDING PROTEINS; FEMALE; HEMODYNAMICS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INFANT, VERY LOW BIRTH WEIGHT; LIPOCALINS; MALE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; PROTO-ONCOGENE PROTEINS;

EID: 84855393695     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000334826     Document Type: Article

References (29)

1. Chiruvolu A, Punjwani P, Ramaciotti C: Clinical and echocardiographic diagnosis of patent ductus arteriosus in premature neonates. Early Hum Dev 2009;85:147-149.
2. Jhaveri N, Moon-Grady A, Clyman RI: Early surgical ligation versus a conservative approach for management of patent ductus arteriosus that fails to close after indomethacin treatment. J Pediatr 2010;157:381-387, 387 e381.
3. Laughon M, Bose C, Benitz WE: Patent ductus arteriosus management: what are the next steps? J Pediatr 2010;157:355-357.
4. Sehgal A, Coombs P, Tan K, McNamara PJ: Spectral Doppler waveforms in systemic arteries and physiological significance of a patent ductus arteriosus. J Perinatol 2011;31:150-156.
5. El-Khuffash A, Higgins M, Walsh K, Molloy EJ: Quantitative assessment of the degree of ductal steal using celiac artery blood flow to left ventricular output ratio in preterm infants. Neonatology 2008;93:206-212. (Pubitemid 351450448)
6. Kwinta P, Rudzinski A, Kruczek P, Kordon Z, Pietrzyk JJ: Can early echocardiographic findings predict patent ductus arteriosus? Neonatology 2009;95:141-148.
7. Farombi-Oghuvbu I, Matthews T, Mayne PD, Guerin H, Corcoran JD: N-terminal pro-B-type natriuretic peptide: a measure of significant patent ductus arteriosus. Arch Dis Child Fetal Neonatal Ed 2008;93:F257-F260. (Pubitemid 352039393)
8. Attridge JT, Kaufman DA, Lim DS: B-type natriuretic peptide concentrations to guide treatment of patent ductus arteriosus. Arch Dis Child Fetal Neonatal Ed 2009;94:F178-F182.
9. Czernik C, Lemmer J, Metze B, Koehne PS, Mueller C, Obladen M: B-type natriuretic peptide to predict ductus intervention in infants <28 weeks. Pediatr Res 2008;64:286-290.
10. Letzner J, Berger F, Schwabe S, Benzing J, Morgenthaler NG, Bucher HU, Buhrer C, Arlettaz R, Wellmann S: Plasma C-terminal pro-endothelin-1 and the natriuretic pro-peptides NT-proBNP and MR-proANP in very preterm infants with patent ductus arteriosus. Neonatology 2011;101:116-124.
11. Ko HK, Lee JH, Choi BM, Lee JH, Yoo KH, Son CS, Lee JW: Utility of the rapid B-type natriuretic peptide assay for detection of cardiovascular problems in newborn infants with respiratory difficulties. Neonatology 2008;94:16-21. (Pubitemid 351896589)
12. Bolignano D, Donato V, Coppolino G, Campo S, Buemi A, Lacquaniti A, Buemi M: Neutrophil gelatinase-associated lipocalin as a marker of kidney damage. Am J Kidney Dis 2008;52:595-605.
13. Ling W, Zhaohui N, Ben H, Leyi G, Jianping L, Huili D, Jiaqi Q: Urinary IL-18 and NGAL as early predictive biomarkers in contrast-induced nephropathy after coronary angiography. Nephron Clin Pract 2008;108:c176-c181. (Pubitemid 351588109)
14. Krawczeski CD, Woo JG, Wang Y, Bennett MR, Ma Q, Devarajan P: Neutrophil gelatinase-associated lipocalin concentrations predict development of acute kidney injury in neonates and children after cardiopulmonary bypass. J Pediatr 2011;158:1009-1015 e1001.
15. Pelsers MM, Hermens WT, Glatz JF: Fatty acid-binding proteins as plasma markers of tissue injury. Clin Chim Acta 2005;352:15-35. (Pubitemid 40093855)
16. Guthmann F, Borchers T, Wolfrum C, Wustrack T, Bartholomaus S, Spener F: Plasma concentration of intestinal- and liver-FABP in neonates suffering from necrotizing enterocolitis and in healthy preterm neonates. Mol Cell Biochem 2002;239:227-234. (Pubitemid 35385814)
17. Capoluongo E, Vento G, Lulli P, Di Stasio E, Porzio S, Vendettuoli V, Tana M, Tirone C, Romagnoli C, Zuppi C, Ameglio F: Epithelial lining fluid neutrophil-gelatinase-associated lipocalin levels in premature newborns with bronchopulmonary dysplasia and patency of ductus arteriosus. Int J Immunopathol Pharmacol 2008;21:173-179. (Pubitemid 351501013)
18. Sanjeev S, Pettersen M, Lua J, Thomas R, Shankaran S, L'Ecuyer T: Role of plasma B-type natriuretic peptide in screening for hemodynamically significant patent ductus arteriosus in preterm neonates. J Perinatol 2005;25:709-713. (Pubitemid 41655645)
19. Dahl M, Kamper J: Physical outcome and school performance of very-low-birthweight infants treated with minimal handling and early nasal CPAP. Acta Paediatr 2006;95:1099-1103. (Pubitemid 44385116)
20. Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, Ruff SM, Zahedi K, Shao M, Bean J, Mori K, Barasch J, Devarajan P: Neutrophil gelatinase-associated lipocalin as a biomarker for acute renal injury after cardiac surgery. Lancet 2005;365:1231-1238. (Pubitemid 40469655)
21. Hirsch R, Dent C, Pfriem H, Allen J, Beekman RH 3rd, Ma Q, Dastrala S, Bennett M, Mitsnefes M, Devarajan P: NGAL is an early predictive biomarker of contrast-induced nephropathy in children. Pediatr Nephrol 2007;22:2089-2095. (Pubitemid 350090716)
22. Lavery AP, Meinzen-Derr JK, Anderson E, Ma Q, Bennett MR, Devarajan P, Schibler KR: Urinary NGAL in premature infants. Pediatr Res 2008;64:423-428.
23. Huynh TK, Bateman DA, Parravicini E, Lorenz JM, Nemerofsky SL, Sise ME, Bowman TM, Polesana E, Barasch JM: Reference values of urinary neutrophil gelatinase-associated lipocalin in very low birth weight infants. Pediatr Res 2009;66:528-532.
24. Niizeki T, Takeishi Y, Arimoto T, Nozaki N, Hirono O, Watanabe T, Nitobe J, Miyashita T, Miyamoto T, Koyama Y, Kitahara T, Suzuki S, Sasaki T, Kubota I: Persistently increased serum concentration of heart-type fatty acid-binding protein predicts adverse clinical outcomes in patients with chronic heart failure. Circ J 2008;72:109-114. (Pubitemid 351413337)
25. Hasegawa T, Yoshimura N, Oka S, Ootaki Y, Toyoda Y, Yamaguchi M: Evaluation of heart fatty acid-binding protein as a rapid indicator for assessment of myocardial damage in pediatric cardiac surgery. J Thorac Cardiovasc Surg 2004;127:1697-1702. (Pubitemid 38725450)
26. Pelsers MM: Fatty acid-binding protein as marker for renal injury. Scand J Clin Lab Invest Suppl 2008;241:73-77.
27. Nuntnarumit P, Khositseth A, Thanomsingh P: N-terminal probrain natriuretic peptide and patent ductus arteriosus in preterm infants. J Perinatol 2009;29:137-142.
28. Alagarsamy S, Chhabra M, Gudavalli M, Nadroo AM, Sutija VG, Yugrakh D: Comparison of clinical criteria with echocardiographic findings in diagnosing PDA in preterm infants. J Perinat Med 2005;33:161-164. (Pubitemid 40477078)
29. El-Khuffash AF, Amoruso M, Culliton M, Molloy EJ: N-terminal pro-B-type natriuretic peptide as a marker of ductal haemodynamic significance in preterm infants: a prospective observational study. Arch Dis Child Fetal Neonatal Ed 2007;92:F421-F422. (Pubitemid 47436237)